Axinn Advises McKesson on $875M Acquisition of Rx Savings Solutions
September 19, 2022
Axinn is representing McKesson Corporation (NYSE: MCK), a diversified health care services leader, in its $875M acquisition of Rx Savings Solutions, a prescription price transparency and benefit insight company. Announced on September 19, 2022, the acquisition will strengthen McKesson’s ability to help solve the most common medication challenges related to access, affordability and adherence. The Axinn team is led by partners Daniel Bitton and Jeny Maier, and assisted by associate Neelesh Moorthy.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
DC Bar: The DOJ's New Antitrust Whistleblower Rewards Program: An Overview and the Road Ahead
Speaking Engagement
Antitrust
Informa Antitrust Midwest 2026
Speaking Engagement
Antitrust
National LGBTQ+ Bar Association Lavender Law Conference and Career Fair 2026
Sponsorship
What’s Up? Enforcement Updates From the Middle East and Africa
Podcast
Antitrust
AHLA Annual Meeting & In-House Counsel Program
Sponsorship
Antitrust
Lexology In-Depth: Intellectual Property and Antitrust (2026)
Byline Articles
Intellectual Property
Tracking The Rare 'Quick Look' Win In FTC's Zillow-Redfin Suit
Byline Articles
Antitrust
Gleiss Lutz Annual Antitrust Law Conference
Speaking Engagement
Antitrust
What Top Law Firms Say New Lawyers Need in the AI Era
Media Mentions
What’s the Role of Communications Strategy in M&A? How Public Affairs Impacts Antitrust
Podcast
Antitrust